Nuveen Asset Management, LLC Coherus Bio Sciences, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 95,056 shares of CHRS stock, worth $79,847. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,056

Previous 95,056 -0.0%

Holding current value

$79,847

Previous $98,000 33.67%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.02 - $3.14 $1.35 Million - $2.09 Million	-666,263 Reduced 87.51%	95,056 $227,000
Q4 2023 Feb 14, 2024	SELL	$1.59 - $3.85 $348,855 - $844,713	-219,406 Reduced 22.37%	761,319 $2.54 Million
Q3 2023 Nov 14, 2023	BUY	$3.74 - $5.45 $2.62 Million - $3.82 Million	700,899 Added 250.48%	980,725 $3.67 Million
Q2 2023 Aug 14, 2023	BUY	$3.79 - $8.3 $394,792 - $864,586	104,167 Added 59.3%	279,826 $1.19 Million
Q1 2023 May 15, 2023	SELL	$5.89 - $10.52 $1.69 Million - $3.02 Million	-286,867 Reduced 62.02%	175,659 $1.2 Million
Q4 2022 Feb 14, 2023	SELL	$5.69 - $10.07 $1.52 Million - $2.69 Million	-266,911 Reduced 36.59%	462,526 $3.66 Million
Q3 2022 Nov 14, 2022	SELL	$7.17 - $13.87 $1.13 Million - $2.19 Million	-158,148 Reduced 17.82%	729,437 $7.01 Million
Q2 2022 Aug 15, 2022	SELL	$5.86 - $13.23 $832,243 - $1.88 Million	-142,021 Reduced 13.79%	887,585 $6.43 Million
Q1 2022 May 16, 2022	BUY	$10.92 - $16.41 $3.53 Million - $5.31 Million	323,408 Added 45.8%	1,029,606 $12.5 Million
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $280,548 - $336,977	-17,745 Reduced 2.45%	706,198 $11.3 Million
Q3 2021 Nov 12, 2021	SELL	$12.68 - $17.79 $466,471 - $654,458	-36,788 Reduced 4.84%	723,943 $11.6 Million
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $1.09 Million - $1.29 Million	83,940 Added 12.4%	760,731 $10.5 Million
Q1 2021 May 17, 2021	BUY	$14.42 - $21.39 $230,503 - $341,919	15,985 Added 2.42%	676,791 $9.89 Million
Q4 2020 May 17, 2021	SELL	$16.56 - $18.94 $520,199 - $594,962	-31,413 Reduced 4.54%	660,806 $11.5 Million
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $7.41 Million - $8.48 Million	-447,652 Reduced 39.27%	692,219 $12 Million
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $52,299 - $59,749	-3,004 Reduced 0.26%	1,139,871 $20.9 Million
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $1.46 Million - $1.93 Million	-100,961 Reduced 8.12%	1,142,875 $20.4 Million
Q1 2020 May 14, 2020	SELL	$11.67 - $22.53 $8.14 Million - $15.7 Million	-697,864 Reduced 35.94%	1,243,836 $20.2 Million
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $1.83 Million - $2.39 Million	111,785 Added 6.11%	1,941,700 $35 Million
Q3 2019 Nov 14, 2019	BUY	$16.3 - $23.37 $10.9 Million - $15.6 Million	667,224 Added 57.39%	1,829,915 $37.1 Million
Q2 2019 Aug 15, 2019	BUY	$13.1 - $22.1 $15.2 Million - $25.7 Million	1,162,691 New	1,162,691 $25.7 Million

Others Institutions Holding CHRS

# of Institutions

130

Shares Held

67.8M

Call Options Held

1.68M

Put Options Held

91.8K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $65.3M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Coherus Bio Sciences, Inc. Transaction History